Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Sartorius Stedim Biotech
  6. Summary
    DIM   FR0013154002

SARTORIUS STEDIM BIOTECH

(DIM)
  Report
Real-time Quote. Real-time Euronext Paris - 07/23 11:35:23 am
461.9 EUR   +1.27%
07/21GLOBAL MARKETS LIVE : Netflix, Novartis, Tesla, Autodesk, AMC...
07/21SARTORIUS VORZUEGE : JP Morgan keeps its Buy rating
MD
07/21SARTORIUS VORZUEGE : Sell rating from UBS
MD
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Real-time Quote. Real-time Euronext Paris
07/19/2021 07/20/2021 07/21/2021 07/22/2021 07/23/2021 Date
457.4(c) 450.5(c) 438.6(c) 456.1(c) 461.9(c) Last
78 043 63 448 97 378 48 289 41 091 Volume
-0.63% -1.51% -2.64% +3.99% +1.27% Change
More quotes
Estimated financial data (e)
Sales 2021 2 813 M 3 310 M 3 310 M
Net income 2021 576 M 678 M 678 M
Net Debt 2021 673 M 792 M 792 M
P/E ratio 2021 73,9x
Yield 2021 0,28%
Sales 2022 3 087 M 3 633 M 3 633 M
Net income 2022 601 M 708 M 708 M
Net Debt 2022 241 M 284 M 284 M
P/E ratio 2022 73,4x
Yield 2022 0,35%
Capitalization 42 578 M 50 086 M 50 106 M
EV / Sales 2021 15,4x
EV / Sales 2022 13,9x
Nbr of Employees 8 746
Free-Float 26,2%
More Financials
Company
Sartorius Stedim Biotech SA is a France-based international provider of laboratory and process technologies and equipment. The Company covers the segments of biotechnology and mechatronics. Sartorius provides services which help customers to implement complex and quality-critical processes in biopharmaceutical production and laboratory environments in a time- and cost-efficient way. The Company’s customers are... 
More about the company
Ratings of Sartorius Stedim Biotech
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about SARTORIUS STEDIM BIOTECH
07/21GLOBAL MARKETS LIVE : Netflix, Novartis, Tesla, Autodesk, AMC...
07/21SARTORIUS VORZUEGE : JP Morgan keeps its Buy rating
MD
07/21SARTORIUS VORZUEGE : Sell rating from UBS
MD
07/21SARTORIUS STEDIM BIOTECH : Conference Call H1|2021 Presentation
PU
07/21SARTORIUS VORZUEGE : Gets a Buy rating from Warburg Research
MD
07/21SARTORIUS STEDIM BIOTECH : Half-Year Report H1|2021
PU
07/21SARTORIUS : Life Sciences Group Sartorius' Profit Soars 109% in H1 on Sustained ..
MT
07/21SARTORIUS STEDIM BIOTECH : H1 Profit As Order Intake Surges 80%
MT
07/21SARTORIUS STEDIM BIOTECH SA : Information on Document Availability
DJ
07/21SARTORIUS STEDIM BIOTECH SA : Communiqué de mise à disposition de documents
DJ
07/21SARTORIUS STEDIM BIOTECH : continues on its fast growth trajectory – signi..
PU
07/21SARTORIUS STEDIM BIOTECH : Half-year results of Sartorius Stedim Biotech
PU
07/20Sartorius Stedim Biotech S.A. Reports Earnings Results for the Second Quarter..
CI
07/16SARTORIUS STEDIM BIOTECH : Financial Data H1|2021
PU
07/06GLOBAL MARKETS LIVE : Facebook, AngloGold, Didi, Weibo, Daimler...
More news
News in other languages on SARTORIUS STEDIM BIOTECH
07/24HINTERGRUND/FRISCHER WIND FÜR DEN DA : Wer steigt im September auf?
07/21MÄRKTE EUROPA/Erholung gewinnt an Dynamik
07/21XETRA-SCHLUSS/Kräftig erholt - nur SAP kann den DAX bremsen
07/21SARTORIUS STEDIM BIOTECH : Rapport financier semestriel de janvier à juin 2021
07/21MÄRKTE EUROPA/Nur SAP bremst die DAX-Erholung
More news
Analyst Recommendations on SARTORIUS STEDIM BIOTECH
More recommendations
Stock Trading Strategies
SARTORIUS STEDIM BIOTECH - 07/06
Close to a key resistance level
BUY
More Stock Trading Analysis
Chart SARTORIUS STEDIM BIOTECH
Duration : Period :
Sartorius Stedim Biotech Technical Analysis Chart | DIM | FR0013154002 | MarketScreener
Technical analysis trends SARTORIUS STEDIM BIOTECH
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 461,90 €
Average target price 431,00 €
Spread / Average Target -6,69%
EPS Revisions
Managers and Directors
Joachim Kreuzburg Chairman & Chief Executive Officer
Oscar-Werner Reif Executive VP-Research & Development
Volker Niebel Executive VP-Operations & Information Technology
Henri Riey Independent Non-Executive Director
Anne-Marie Graffin Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
SARTORIUS STEDIM BIOTECH58.62%43 277
ABBOTT LABORATORIES10.33%200 283
MEDTRONIC PLC9.73%168 081
BECTON, DICKINSON AND COMPANY0.34%70 145
HOYA CORPORATION3.33%50 251
ALIGN TECHNOLOGY, INC.19.44%48 667